Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Canopy Growth is a drug manufacturers - specialty & generic business based in the US. Canopy Growth shares (CGC) are listed on the NASDAQ and all prices are listed in US Dollars. Canopy Growth employs 1,621 staff and has a trailing 12-month revenue of around $362.2 million.
| Latest market close | $6.49 |
|---|---|
| 52-week range | $2.76 - $19.20 |
| 50-day moving average | $5.07 |
| 200-day moving average | $5.62 |
| Wall St. target price | $4.38 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-15.67 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $6.49 from 2024-04-17
| 1 week (2024-04-11) | -20.37% |
|---|---|
| 1 month (2024-03-18) | 74.93% |
| 3 months (2024-01-18) | 46.17% |
| 6 months (2023-10-18) | 989.11% |
| 1 year (2023-04-18) | 353.85% |
|---|---|
| 2 years (2022-04-14) | -4.84% |
| 3 years (2021-04-16) | 27.8 |
| 5 years (2019-04-18) | 44.56 |
| Revenue TTM | $362.2 million |
|---|---|
| Gross profit TTM | $-81,938,000 |
| Return on assets TTM | -8.89% |
| Return on equity TTM | -121.56% |
| Profit margin | 0% |
| Book value | $6.57 |
| Market Capitalization | $742.6 million |
TTM: trailing 12 months
We're not expecting Canopy Growth to pay a dividend over the next 12 months.
Canopy Growth's shares were split on a 1:10 basis on 19 December 2023. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Canopy Growth shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Canopy Growth shares which in turn could have impacted Canopy Growth's share price.
Over the last 12 months, Canopy Growth's shares have ranged in value from as little as $2.755 up to $19.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Canopy Growth's is 1.635. This would suggest that Canopy Growth's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
We analyze robo-advisors across 7 key metrics to see how they compare.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
Features and fees to consider before you open an account with this trading platform.
SoFi is a commission-free platform with both active and automated investment accounts.
What you need to know about investing in the leading indicator for the overall US stock market.
Take advantage of $0 trades and no investment minimums with this well-known broker.
A deep dive into the highlights and limitations of Robinhood.